BCMA (CD269), the major target for BsAb in MM, is a member of the tumor necrosis factor receptor (TNFR) family which promotes cell proliferation and survival after binding its ligands APRIL (A Proliferation Inducing Ligand) and BAFF (B cell Activating Factor). This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.